Literature DB >> 24738675

Daclatasvir plus sofosbuvir for HCV infection.

Harpal S Dhaliwal, Ram V Nampoothiri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24738675     DOI: 10.1056/NEJMc1401726

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  Labour productivity losses caused by premature death associated with hepatitis C in Spain.

Authors:  Juan Oliva-Moreno; Luz M Peña-Longobardo; Sonia Alonso; Antonio Fernández-Bolaños; María Luisa Gutiérrez; Álvaro Hidalgo-Vega; Elsa de la Fuente; Conrado M Fernández-Rodríguez
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-06       Impact factor: 2.566

3.  The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis.

Authors:  Jennifer R Reed; Ashly E Jordan; David C Perlman; Daniel J Smith; Holly Hagan
Journal:  Syst Rev       Date:  2016-07-11

Review 4.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

5.  Transmission genetics of drug-resistant hepatitis C virus.

Authors:  Nicholas van Buuren; Timothy L Tellinghuisen; Christopher D Richardson; Karla Kirkegaard
Journal:  Elife       Date:  2018-03-28       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.